"Designing Growth Strategies is in our DNA"

Biopharmaceutical CMO Downstream Processing Market Size, Share & Industry Analysis, By Technique (Purification, Concentration, and Others), By Source (Mammalian and Non-mammalian), By Product (Biologics and Biosimilars), and Regional Forecast, 2026-2034

Last Updated: June 22, 2026 | Format: PDF | Report ID: FBI114912

 


To get information on various segments, share your queries with us

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 16.57% from 2026-2034
Unit Value (USD Billion)
Segmentation

By Technique

  • Purification
  • Concentration
  • Others

By Source

  • Mammalian
  • Non-mammalian

By Product

  • Biologics
  • Biosimilars

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
  • 2021-2034
  • 2025
  • 2021-2024
  • 130
Download Free Sample

    man icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann